FI963881L - 5H-indeno/1,2-b/pyratsin-2,3-dionijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet - Google Patents

5H-indeno/1,2-b/pyratsin-2,3-dionijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet Download PDF

Info

Publication number: FI963881L
Authority: FI; Finland
Prior art keywords: indeno; pyrazine; preparation; products containing; medicinal products
Prior art date: 1994-03-28

Application number

FI963881A

Other languages

English (en)

Swedish (sv)

Other versions

FI963881A0 (fi

FI112219B (fi

Inventor

Jean-Claude Aloup

Francois Audiau

Michel Barreau

Dominique Damour

Arielle Genevois-Borella

Patrick Jimonet

Serge Magnani

Yves Ribeill

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-28

Filing date

1996-09-27

Publication date

1996-09-27

1996-09-27 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1996-09-27 Publication of FI963881A0 publication Critical patent/FI963881A0/fi

1996-09-27 Publication of FI963881L publication Critical patent/FI963881L/fi

2003-11-14 Application granted granted Critical

2003-11-14 Publication of FI112219B publication Critical patent/FI112219B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Liquid Crystal Substances (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

FI963881A 1994-03-28 1996-09-27 5H-indeno[1,2-b]pyratsin-2,3-dionijohdannaiset ja niitä sisältävät lääkeaineet FI112219B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR9403583A FR2717805B1 (fr)	1994-03-28	1994-03-28	Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .
FR9403583		1994-03-28
FR9500359		1995-01-13
PCT/FR1995/000359 WO1995026342A1 (fr)	1994-03-28	1995-03-23	DERIVES DE 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT

Publications (3)

Publication Number	Publication Date
FI963881A0 FI963881A0 (fi)	1996-09-27
FI963881L true FI963881L (fi)	1996-09-27
FI112219B FI112219B (fi)	2003-11-14

Family

ID=9461468

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI963881A FI112219B (fi)	1994-03-28	1996-09-27	5H-indeno[1,2-b]pyratsin-2,3-dionijohdannaiset ja niitä sisältävät lääkeaineet

Country Status (20)

Country	Link
US (1)	US5922716A (fi)
EP (1)	EP0752988B1 (fi)
JP (1)	JP3942631B2 (fi)
KR (1)	KR970702262A (fi)
AT (1)	ATE180476T1 (fi)
AU (1)	AU692853B2 (fi)
BR (1)	BR9507446A (fi)
CA (1)	CA2184754A1 (fi)
DE (1)	DE69509886T2 (fi)
DK (1)	DK0752988T3 (fi)
ES (1)	ES2134460T3 (fi)
FI (1)	FI112219B (fi)
FR (1)	FR2717805B1 (fi)
GR (1)	GR3030274T3 (fi)
HU (1)	HUT75307A (fi)
IL (1)	IL113149A0 (fi)
NO (1)	NO308075B1 (fi)
PL (1)	PL316442A1 (fi)
WO (1)	WO1995026342A1 (fi)
ZA (1)	ZA952525B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK12293D0 (da) *	1993-02-02	1993-02-02	Novo Nordisk As	Heterocykliske forbindelser og deres fremstilling og anvendelse
FR2743363A1 (fr) *	1996-01-10	1997-07-11	Rhone Poulenc Rorer Sa	5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US6083986A (en) *	1996-07-26	2000-07-04	Icagen, Inc.	Potassium channel inhibitors
US6333337B1 (en)	1998-01-27	2001-12-25	Icagen, Inc.	Potassium channel inhibitors
WO2001046155A1 (en)	1999-12-21	2001-06-28	Icagen, Inc.	Potassium channel inhibitors
US6566380B2 (en)	2000-07-25	2003-05-20	Icagen, Inc.	Potassium channel inhibitors
US6620849B2 (en)	2000-07-26	2003-09-16	Icafen, Inc.	Potassium channel inhibitors
US6849634B2 (en)	2000-12-21	2005-02-01	Icagen	Potassium channel inhibitors
JP2005506292A (ja) *	2001-03-08	2005-03-03	エモリー　ユニバーシティ	ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
US20040082543A1 (en) *	2002-10-29	2004-04-29	Pharmacia Corporation	Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
US7732162B2 (en)	2003-05-05	2010-06-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
JP5379692B2 (ja)	2006-11-09	2013-12-25	プロビオドルグエージー	潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
US9126987B2 (en)	2006-11-30	2015-09-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase
AU2008220785B2 (en)	2007-03-01	2013-02-21	Vivoryon Therapeutics N.V.	New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja)	2007-04-18	2015-02-12	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
AU2008272964A1 (en)	2007-06-29	2009-01-08	Emory University	NMDA receptor antagonists for neuroprotection
NZ598685A (en)	2009-09-11	2013-05-31	Probiodrug Ag	Heterocylcic derivatives as inhibitors of glutaminyl cyclase
JP6026284B2 (ja)	2010-03-03	2016-11-16	プロビオドルグエージー	グルタミニルシクラーゼの阻害剤
DK2545047T3 (da)	2010-03-10	2014-07-28	Probiodrug Ag	Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
EP2560953B1 (en)	2010-04-21	2016-01-06	Probiodrug AG	Inhibitors of glutaminyl cyclase
CN101906051B (zh) *	2010-07-13	2013-01-23	成都理工大学	手性氨基茚酮的合成方法
US8530670B2 (en)	2011-03-16	2013-09-10	Probiodrug Ag	Inhibitors
EP3461819B1 (en)	2017-09-29	2020-05-27	Probiodrug AG	Inhibitors of glutaminyl cyclase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4507300A (en) *	1980-05-09	1985-03-26	Usv Pharmaceutical Corporation	Pyridotriazolopyrazine-diones for treating allergy
US4668678A (en) *	1980-05-09	1987-05-26	Usv Pharmaceutical Corporation	Triazoloquinoxalin-1,4-diones
US4400382A (en) *	1980-05-09	1983-08-23	Usv Pharmaceutical Corporation	Thiazoloquinoxalin-1,4-diones for treating allergy
US4354027A (en) *	1980-05-19	1982-10-12	Usv Pharmaceutical Corporation	Triazoloquinoxalin-4-ones
US5196421A (en) *	1991-06-05	1993-03-23	Eli Lilly And Company	Excitatory amino acid receptor antagonists in methods for the use thereof
US5153196A (en) *	1991-06-05	1992-10-06	Eli Lilly And Company	Excitatory amino acid receptor antagonists and methods for the use thereof
DK162491D0 (da) *	1991-09-20	1991-09-20	Novo Nordisk As	Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
PT647137E (pt) *	1992-06-22	2008-11-24	Univ California	Antagonistas dos receptores da glicina e a sua utilização
FR2696466B1 (fr) *	1992-10-02	1994-11-25	Rhone Poulenc Rorer Sa	Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.
DK12293D0 (da) *	1993-02-02	1993-02-02	Novo Nordisk As	Heterocykliske forbindelser og deres fremstilling og anvendelse
FR2707643B1 (fr) *	1993-07-16	1995-08-11	Rhone Poulenc Rorer Sa	Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
FR2707645B1 (fr) *	1993-07-16	1995-08-11	Rhone Poulenc Rorer Sa	Dérivés d'imidazo[1,2-a]pirazine-4-one, leur préparation et les médicaments les contenant.

1994
- 1994-03-28 FR FR9403583A patent/FR2717805B1/fr not_active Expired - Fee Related
1995
- 1995-03-02 CA CA002184754A patent/CA2184754A1/fr not_active Abandoned
- 1995-03-23 ES ES95914405T patent/ES2134460T3/es not_active Expired - Lifetime
- 1995-03-23 HU HU9602658A patent/HUT75307A/hu unknown
- 1995-03-23 PL PL95316442A patent/PL316442A1/xx unknown
- 1995-03-23 AU AU21414/95A patent/AU692853B2/en not_active Ceased
- 1995-03-23 EP EP95914405A patent/EP0752988B1/fr not_active Expired - Lifetime
- 1995-03-23 US US08/714,164 patent/US5922716A/en not_active Expired - Fee Related
- 1995-03-23 JP JP52499695A patent/JP3942631B2/ja not_active Expired - Fee Related
- 1995-03-23 AT AT95914405T patent/ATE180476T1/de not_active IP Right Cessation
- 1995-03-23 DE DE69509886T patent/DE69509886T2/de not_active Expired - Fee Related
- 1995-03-23 BR BR9507446A patent/BR9507446A/pt not_active Application Discontinuation
- 1995-03-23 DK DK95914405T patent/DK0752988T3/da active
- 1995-03-23 WO PCT/FR1995/000359 patent/WO1995026342A1/fr not_active Ceased
- 1995-03-27 IL IL11314995A patent/IL113149A0/xx unknown
- 1995-03-28 ZA ZA952525A patent/ZA952525B/xx unknown
1996
- 1996-09-25 KR KR1019960705453A patent/KR970702262A/ko not_active Withdrawn
- 1996-09-26 NO NO964059A patent/NO308075B1/no not_active IP Right Cessation
- 1996-09-27 FI FI963881A patent/FI112219B/fi active
1999
- 1999-05-27 GR GR990400320T patent/GR3030274T3/el unknown

Also Published As

Publication number	Publication date
GR3030274T3 (en)	1999-08-31
DE69509886T2 (de)	1999-09-30
AU692853B2 (en)	1998-06-18
JPH09510728A (ja)	1997-10-28
FR2717805B1 (fr)	1996-05-10
FR2717805A1 (fr)	1995-09-29
FI963881A0 (fi)	1996-09-27
ES2134460T3 (es)	1999-10-01
WO1995026342A1 (fr)	1995-10-05
BR9507446A (pt)	1997-08-12
NO964059D0 (no)	1996-09-26
JP3942631B2 (ja)	2007-07-11
PL316442A1 (en)	1997-01-20
DE69509886D1 (de)	1999-07-01
IL113149A0 (en)	1995-06-29
NO964059L (no)	1996-09-26
KR970702262A (ko)	1997-05-13
EP0752988B1 (fr)	1999-05-26
DK0752988T3 (da)	1999-11-08
CA2184754A1 (fr)	1995-10-05
FI112219B (fi)	2003-11-14
EP0752988A1 (fr)	1997-01-15
US5922716A (en)	1999-07-13
HU9602658D0 (en)	1996-11-28
ATE180476T1 (de)	1999-06-15
AU2141495A (en)	1995-10-17
NO308075B1 (no)	2000-07-17
ZA952525B (en)	1996-01-15
HUT75307A (en)	1997-05-28

Publication	Publication Date	Title
FI963881L (fi)	1996-09-27	5H-indeno/1,2-b/pyratsin-2,3-dionijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
FI940072L (fi)	1994-01-07	Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
FI943570A7 (fi)	1995-01-31	1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
EE9700145A (et)	1998-02-16	Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
FI943421L (fi)	1994-07-19	1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä
IS4839A (is)	1998-08-28	Nýjar bensazepín afleiður, læknislyf sem innihalda þær og notkun þeirra við að útbúa læknislyf
FI934274A7 (fi)	1993-09-29	N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset
IL112384A0 (en)	1995-03-30	Tetracyclic derivatives, their preparation and pharmaceutical compositions containing them
FI953479A7 (fi)	1996-01-20	1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
EE03774B1 (et)	2002-06-17	5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
FI953898A0 (fi)	1995-08-18	Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
PL321003A1 (en)	1997-11-24	Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
FI931336A7 (fi)	1993-09-29	Polyhydroksimetyleenijohdannaisia sisältäviä lääkkeitä, menetelmä niiden valmistamiseksi ja käyttämiseksi
EE9600172A (et)	1997-06-16	Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
FI955140A7 (fi)	1995-10-27	Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkke issä
AU6675490A (en)	1991-06-20	Heterocyclic derivatives, their preparation and medicinal products containing them
FI960160A7 (fi)	1996-01-12	Imidatso/1,2-a/pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
DE3685604D1 (de)	1992-07-16	1,7-naphthyridinderivate und diese enthaltende arzneimittel.
EE03312B1 (et)	2000-12-15	Asendatud arüülalküültioalküültiopüridiinid Helicobacter bakterite tõrjeks, nende valmistamismeetod ja kasutamine ravimite valmistamiseks
AU3352593A (en)	1993-09-01	Pyridine derivatives, their preparation and use as medicines
FI903589A7 (fi)	1991-01-18	Lääkkeitä, jotka pohjautuvat 4,1,2-1H-bentsoksadiatsiinin johdannaisiin, uusia johdannaisia ja menetelmiä niiden valmistamiseksi
EE9800109A (et)	1998-10-15	5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
IL113151A0 (en)	1995-06-29	Imidazo [1,2-a]pyrazin-4-one derivatives their preparation and medicinal products containing them
FI970434L (fi)	1997-01-31	Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä
ZA902866B (en)	1991-02-27	Substituted azetidinylisothiazolopyridone derivatives,their preparation and their application as medicinal products

Legal Events

Date	Code	Title	Description
2004-11-03	PC	Transfer of assignment of patent	Owner name: AVENTIS PHARMA S.A.